Mount Sinai Announces First-of-its-Kind Center For Post-COVID Care

Newswise — (New York, NY – May 13, 2020) Mount Sinai Health System (MSHS) is launching a new Center for Post-COVID Care for patients recovering from the virus as they transition from hospital to home. The Center, located at Mount Sinai-Union Square, will serve as a destination for patients across MSHS and will provide comprehensive multi-specialty care and systematic evaluation of the long-term impact of COVID-19. 

Although many patients with the virus experience upper airway and respiratory symptoms in the acute setting, mounting evidence suggests that these patients are also at risk for multiple systemic complications including thromboembolic disease, systemic inflammatory response syndrome, cardiovascular complications, and hepatic and renal impairment. Moreover, emerging evidence has identified striking disparities in outcomes for different patient groups, identifying older age, chronic illness, obesity, and disadvantaged socioeconomic status as important risk factors. The long-term complications of acute infection are still unknown

“Mount Sinai has been at the epicenter of the coronavirus pandemic, treating more than 8,000 patients diagnosed with COVID-19,” said Barbara Murphy, MD, Murray M. Rosenberg Professor and Chair, Department of Medicine, Icahn School of Medicine at Mount Sinai. “The entire research and clinical community has raced to understand this virus and has swiftly moved treatment and testing innovations from the lab to the bedside. The Center continues that excellence by caring for a wide spectrum of patients—from those just diagnosed to those already discharged from the hospital and those who were never hospitalized but need help recovering. Patients treated at the Center will receive comprehensive clinical care and diagnostics in collaboration with multiple medical specialties including diagnostic and supportive services.”

The Center will serve as a destination for patients across the MSHS and beyond who are seeking world-class compassionate care in state-of-the-art facilities. A personalized treatment plan will be offered to patients, using advanced diagnostic tools and innovative treatment protocols from key medical specialties including primary care, pulmonary medicine, cardiology, infectious disease, nephrology, physiatry, physical and occupational therapy, radiology, neuropsychiatry, behavioral health, social work, and pharmacy. 

“Mount Sinai’s mission has always been to take care of the needs of our entire community,” said Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System. “COVID-19 will be with us for years to come, and this Center will ensure that all New Yorkers, regardless of their disease state or socioeconomic status, will be able to get the comprehensive, expert care they need for this complex disease.” 

The Center will include a COVID-19 Registry, in which participating patients will undergo a baseline survey to collect information regarding sociodemographics, behaviors, comorbidities, mental health conditions, and medications. Researchers will obtain baseline measures of pulmonary symptoms, cognition and other mental health measures, and physical indicators including biometrics, spirometry, EKG, bloodwork, and antibody titers for SARS-CoV-2, the virus that causes COVID-19.

“This Center will provide a unique opportunity to follow this population and systematically evaluate the long-term impact of COVID-19,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System. “The Center will gather invaluable data to support a broad spectrum of biomedical research, including benchtop science, epidemiology, health services and outcomes, and health policy. We will rapidly translate the insights we gain through this research into better treatments for the wide spectrum of effects that SARS-CoV-2 has on the human body.” 

For information about the Mount Sinai Center for Post-COVID Care, visit https://www.mountsinai.org/about/covid19/center-post-covid-care or call 212-844-6300. 

###

Support Mount Sinai’s COVID-19 Response: Join us in this extraordinary and continuing fight against the COVID-19 pandemic and for health equity. Donate now to support our frontline clinicians who are caring for critically ill patients and our researchers who are furthering understanding of the virus, developing therapies, and addressing the wide-ranging impacts of the pandemic.  Visit www.giving.mountsinai.org.

About the Mount Sinai Health System: The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine at Mount Sinai (ISMMS) as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report. For more information, visit mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.




Filters close

Showing results

110 of 2454
Released: 3-Jul-2020 10:25 AM EDT
Lack of lockdown increased COVID-19 deaths in Sweden
University of Virginia Health System

Sweden’s controversial decision not to lock down during COVID-19 produced more deaths and greater healthcare demand than seen in countries with earlier, more stringent interventions, a new analysis finds.

Released: 2-Jul-2020 3:10 PM EDT
Researchers outline adapted health communications principles for the COVID-19 pandemic
CUNY Graduate School of Public Health and Health Policy

The COVID-19 pandemic has introduced unique challenges for public health practitioners and health communicators that warrant an expansion of existing health communication principles to take into consideration.

Released: 2-Jul-2020 1:40 PM EDT
Collectivism drives efforts to reduce the spread of COVID-19
University of Kent

Research from the University of Kent has found that people who adopt a collectivist mindset are more likely to comply with social distancing and hygiene practices to help reduce the spread of COVID-19.

Released: 2-Jul-2020 12:30 PM EDT
Tiny mineral particles are better vehicles for promising gene therapy
University of Wisconsin-Madison

University of Wisconsin–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination — including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans.

Newswise: Newer variant of COVID-19–causing virus dominates global infections
Released: 2-Jul-2020 12:10 PM EDT
Newer variant of COVID-19–causing virus dominates global infections
Los Alamos National Laboratory

Research out today in the journal Cell shows that a specific change in the SARS-CoV-2 coronavirus virus genome, previously associated with increased viral transmission and the spread of COVID-19, is more infectious in cell culture.

Newswise: From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
Released: 2-Jul-2020 12:05 PM EDT
From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
La Jolla Institute for Immunology

Two variants of the novel coronavirus (SARS-CoV-2), called G614 and D614, were circulating in mid-March. A new study shows that the G version of the virus has come to dominate cases around the world. They report that this mutation does not make the virus more deadly, but it does help the virus copy itself, resulting in a higher viral load, or "titer," in patients.

Released: 2-Jul-2020 11:50 AM EDT
New Study Explains Potential Causes for “Happy Hypoxia” Condition in COVID-19 Patients
Loyola Medicine

A new research study provides possible explanations for COVID-19 patients who present with extremely low, otherwise life-threatening levels of oxygen, but no signs of dyspnea (difficulty breathing). This new understanding of the condition, known as silent hypoxemia or “happy hypoxia,” could prevent unnecessary intubation and ventilation in patients during the current and expected second wave of coronavirus.

Released: 2-Jul-2020 10:15 AM EDT
Stemming the Spread of Misinformation on Social Media
Association for Psychological Science

New research reported in the journal Psychological Science finds that priming people to think about accuracy could make them more discerning in what they subsequently share on social media.

29-Jun-2020 9:00 AM EDT
Coronavirus damages the endocrine system
Endocrine Society

People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.


Showing results

110 of 2454

close
0.77367